Focal Therapy for Prostate Cancer: Is It Being Oversold?

Despite growing enthusiasm for this minimally invasive option for some men with prostate cancer, focal therapy is still not FDA-approved for prostate cancer and comes with high out-of-pocket costs.
Medscape Medical News

source https://www.medscape.com/viewarticle/focal-therapy-prostate-cancer-evidence-based-or-oversold-2024a10003do?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?